Cargando…

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma

Peritoneal sarcomatosis from uterine sarcoma is a rare disease with no effective treatment and poor prognosis. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has successful results in peritoneal carcinomatosis from gastrointestinal/gynecological origins. We show tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardi, Armando, Muñoz‐Zuluaga, Carlos A., Sittig, Michelle, Diaz‐Montes, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986004/
https://www.ncbi.nlm.nih.gov/pubmed/29881584
http://dx.doi.org/10.1002/ccr3.1491
_version_ 1783328855923097600
author Sardi, Armando
Muñoz‐Zuluaga, Carlos A.
Sittig, Michelle
Diaz‐Montes, Teresa
author_facet Sardi, Armando
Muñoz‐Zuluaga, Carlos A.
Sittig, Michelle
Diaz‐Montes, Teresa
author_sort Sardi, Armando
collection PubMed
description Peritoneal sarcomatosis from uterine sarcoma is a rare disease with no effective treatment and poor prognosis. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has successful results in peritoneal carcinomatosis from gastrointestinal/gynecological origins. We show that CRS/HIPEC is safe, feasible, and may benefit selected patients with peritoneal sarcomatosis from uterine sarcoma.
format Online
Article
Text
id pubmed-5986004
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-59860042018-06-07 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma Sardi, Armando Muñoz‐Zuluaga, Carlos A. Sittig, Michelle Diaz‐Montes, Teresa Clin Case Rep Case Reports Peritoneal sarcomatosis from uterine sarcoma is a rare disease with no effective treatment and poor prognosis. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has successful results in peritoneal carcinomatosis from gastrointestinal/gynecological origins. We show that CRS/HIPEC is safe, feasible, and may benefit selected patients with peritoneal sarcomatosis from uterine sarcoma. John Wiley and Sons Inc. 2018-05-02 /pmc/articles/PMC5986004/ /pubmed/29881584 http://dx.doi.org/10.1002/ccr3.1491 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Sardi, Armando
Muñoz‐Zuluaga, Carlos A.
Sittig, Michelle
Diaz‐Montes, Teresa
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma
title Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma
title_full Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma
title_fullStr Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma
title_full_unstemmed Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma
title_short Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma
title_sort cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986004/
https://www.ncbi.nlm.nih.gov/pubmed/29881584
http://dx.doi.org/10.1002/ccr3.1491
work_keys_str_mv AT sardiarmando cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinsevenpatientswithperitonealsarcomatosisfromuterinesarcoma
AT munozzuluagacarlosa cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinsevenpatientswithperitonealsarcomatosisfromuterinesarcoma
AT sittigmichelle cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinsevenpatientswithperitonealsarcomatosisfromuterinesarcoma
AT diazmontesteresa cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinsevenpatientswithperitonealsarcomatosisfromuterinesarcoma